Bioactive molecules in milk and their role in health and disease: The role of transforming growth factor-β

Immunology and Cell Biology

Volumn 78, Issue 1, 2000, Pages 74-79

  Donnet Hughes, A ^a   Duc, N ^a   Serrant, P ^a   Vidal, K ^a   Schiffrin, E J ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bioactive molecules; Crohn's disease; Inflammation; Intestine; Milk; Oral tolerance; Permeability; Transforming growth factor

Indexed keywords

GROWTH FACTOR; HORMONE; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ENTEROPATHY; HUMAN; IMMUNE STATUS; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION; MILK; NONHUMAN;

ANIMALS; CATTLE; CROHN DISEASE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFANT; INFANT, NEWBORN; INTESTINAL MUCOSA; MILK; MILK, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

BOVINAE;

EID: 0033953592     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00882.x     Document Type: Article

References (44)

1. 1 Chandra RK. Nutrition and the immune system: An introduction. Am. J. Clin. Nutr. 1997; 66: S460-3.
2. 2 Fomon SJ. Infant feeding and evolution. In: Fomon SJ (ed.). Nutrition of Normal Infants. St Louis: Mosby, 1993; 1-5.
3. 3 Hanson LA, Ashraf R, Carlsson B et al. The second John Soothill Lecture. Breastfeeding, infections and immunity. In: Chandra RK. (ed.). Nutrition and Immunology. Newfoundland: ARTS Biomedical Publishers and Distributors, 1992; 45-63.
4. 4 Koldovský O, Štrbák V. Hormones and growth factors in human milk. In: Jensen RC (ed.). Handbook of Milk Composition. London: Academic Press, 1995; 428-36.
5. 5 Campana WM, Baumrucker CR. Hormones and growth factors in bovine milk. In: Jensen RC (ed.). Handbook of Milk Composition. London: Academic Press, 1995; 476-93.
6. 6 Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: Possible role in clinical disorders (an update). Gastroenterology 1993; 104: 622-39.
7. 7 Viney JL. Altering cytokine soups: A recipe for inflammatory bowel disease? Gut 1998; 42: 607-8.
8. 8 Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. N. Am. 1995; 24: 475-507.
9. 9 Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol. Rev. 1997; 156: 145-66.
10. 10 Kaiserlian D, Etchart N. Entry sites for oral vaccine and drugs: A role for M cells, enterocytes and dendritic cells? Semin. Immunol. 1999; 11: 217-24.
11. 11 Strober W. Interactions between epithelial cells and immune cells in the intestine. Ann. N. Y. Acad. Sci. 1998; 859: 37-45.
12. 12 Kraehenbuhl JP, Pringault E, Neutra MR. Review article: Intestinal epithelia and barrier functions. Aliment. Pharmacol. Ther. 1997; 11 (Suppl. 3): 3-8.
13. 13 Parr EL, McKenzie IFC. Demonstration of Ia antigens on mouse intestinal epithelial cells by immunoferritin labelling. Immunogenetics 1979; 8: 499-508.
14. 14 Scott H, Solheim BG, Brandtzaeg P, Thorsby E. HLA-DR-like antigens in the epithelium of the human small intestine. Scand. J. Immunol. 1980; 12: 77-82.
15. 15 Mayrhofer G, Pugh CW, Barclay AN. The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen epithelia, with special reference to the small intestine. Eur. J. Immunol. 1983; 13: 112-22.
16. + T cells. Eur. J. Immunol. 1989; 19: 1513-16.
17. 17 Mayer L, Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 1987; 166: 1471-83.
18. 18 Hughes A, Bloch KJ, Bhan AK, Gillen D, Giovino VC, Harmatz PR. Expression of MHC Class II (Ia) antigen by the neonatal enterocytes: The effect of treatment with interferon-gamma. Immunology 1991; 72: 491-6.
19. 19 Sanderson IR, Ouellette AJ, Carter EA, Harmatz PR. Ontogeny of class II MHC mRNA in the mouse small intestinal epithelium. Mol. Immunol. 1992; 29: 1257-63.
20. 20 Mayer L, Eisenhardt D, Salomon P, Bauer W, Plous R, Piccinini L. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 1991; 100: 3-12.
21. 21 Rognum TO, Thrane PS, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr. Res. 1992; 32: 145-9.
22. 22 Mothes T, Bendix U, Pfannschmidt C, Lehmann I. Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells. Gut 1995; 36: 548-52.
23. 23 Sanderson IR, Ouellette AJ, Carter EA, Harmatz PR. Ontogeny of Ia messenger RNA in the mouse small intestinal epithelium is modulated by age of weaning and diet. Gastroenterology 1993; 105: 974-80.
24. 24 Hamilton LJ, Dai Y, Jackson GD. Bile regulates the expression of major histocompatibility complex class II molecules on rat intestinal epithelium. Gastroenterology 1997; 113: 1901-5.
25. 25 Matsumoto S, Setoyama H, Umesaki Y. Differential induction of major histocompatibility complex molecules on mouse intestine by bacterial colonization. Gastroenterology 1992; 103: 1777-82.
26. 26 Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Ann. Rev. Immunol. 1998; 16: 137-61.
27. 27 Border WA, Noble NA. Targeting TGF-β for treatment of disease. Nat. Med. 1995; 1: 1000-1.
28. 28 Czarniecki C, Chiu HH, Wong GHW, McCabe SM, Palladino MA. Transforming growth factor β1 modulates the expression of Class II histocompatibility antigens on human cells. J. Immunol. 1988; 140: 4217-23.
29. 29 Zuber P, Kuppner MC, De Tribolet N. Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur. J. Immunol. 1988; 18: 1623-6.
30. 30 Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-9.
31. 31 Cox DA, Bürk RR. Isolation and characterisation of milk growth factor, a transforming-growth-factor-β2-related polypeptide, from bovine milk. Eur. J. Immunol. 1991; 197: 353-8.
32. 32 Hoang P, Crotty B, Dalton HR, Jewell DP. Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut 1992; 33: 1089-93.
33. 2 in human milk during the first three months postpartum. Pediatr. Res. 1999; 46: 1-6.
34. 34 Lee YJ, Han Y, Lu HT et al. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II trans-activator messenger RNA expression. J. Immunol. 1997; 158: 2065-75.
35. 35 Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998; 14: 345-50.
36. 36 Raouf AH, Hildrey V, Daniel J et al. Enteral feeding as sole treatment for Crohn's disease: Controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut 1991; 32: 702-7.
37. 37 Rhodes JM. Enteral feeding in the treatment of Crohn's disease: Not all polymeric diets are equal. Gastroenterology 1992; 102: 1445-6.
38. 38 Beattie RM, Schiffrin EJ, Donnet-Hughes A etal. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment. Pharmacol. Ther. 1994; 8: 609-15.
39. 39 Fell JME, Hollis A, Paintin M, Arnaud-Battandier F, MacDonald TT, Walker-Smith JA. Normalisation of mucosal cytokine mRNA in association with clinical improvement in children with Crohn's disease treated with polymeric diet. J. Pediatr. Gastroenterol. Nutr. 1998; 26: 544.
40. 40 Beattie RM, Camacho-Hübner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin. Endocrinol. 1998; 49: 483-9.
41. 41 Guo YS, Townsend Jr CM, Jin GF, Beauchamp RD, Thompson JC. Differential regulation by TGF-beta 1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells. Am. J. Physiol. 1995; 268: E1199-204.
42. 42 Voci A, Arvigo M, Massajoli M et al. IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor-alpha and transforming growth factor-beta 1. Eur. J. Endocrinol. 1999; 140: 577-82.
43. 43 Leal SM, Huang SS, Huang JS. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J. Biol. Chem. 1999; 274: 6711-17.
44. 44 Oguchi S, Walker WA, Sanderson IR. Profile of IGF-binding proteins secreted by intestinal epithelial cells changes with differentiation. Am. J. Physiol. 1994; 267: G843-50.